BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:GSK plc (GSK) investor events
X-WR-CALNAME:GSK plc (GSK) investor events
DESCRIPTION:Earnings calls and investor events for GSK plc (GSK)\, from Equ
 ibles.
X-WR-CALDESC:Earnings calls and investor events for GSK plc (GSK)\, from Eq
 uibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:cff71551-e7b4-4fb2-82fb-ce2687a979e6@equibles.com
DTSTAMP:20261010T195203Z
DTSTART;VALUE=DATE:20260204
DTEND;VALUE=DATE:20260205
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.gs
 k.com/en-gb/company/governance/shareholders/
URL:https://equibles.com/stocks/gsk/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:fbc30f9b-8da2-48d2-b2e8-aa747555b10f@equibles.com
DTSTAMP:20260610T190421Z
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.gs
 k.com/investor-relations
URL:https://equibles.com/stocks/gsk/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:3a5a6300-2eed-41e0-87cf-3cefac0423d6@equibles.com
DTSTAMP:20260820T160353Z
DTSTART;VALUE=DATE:20260728
DTEND;VALUE=DATE:20260729
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.gs
 k.com/en-gb/company/governance/shareholders/
URL:https://equibles.com/stocks/gsk/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:623fb196-d100-4053-a3fd-91bfe01154c2@equibles.com
DTSTAMP:20260820T232150Z
DTSTART;VALUE=DATE:20260909
DTEND;VALUE=DATE:20260910
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference: Julie Brown\, Chief Financial Officer\, w
 ill attended and take part in a fireside chat at the Bernstein’s 23rd An
 nual Pan-European Strategic Decisions Conference in London on Wednesday\, 
 9 September 2026.
DESCRIPTION:Julie Brown\, Chief Financial Officer\, will attended and take 
 part in a fireside chat at the Bernstein’s 23rd Annual Pan-European Stra
 tegic Decisions Conference in London on Wednesday\, 9 September 2026.\nThe
  start time has not been announced.\nWebcast: https://cc.webcasts.com/bern
 001/090926a_js/?entity=2_HD36QNE
URL:https://equibles.com/stocks/gsk/events/623fb196-d100-4053-a3fd-91bfe011
 54c2
END:VEVENT
BEGIN:VEVENT
UID:734fb5aa-48f7-4c6e-bd8a-6b287e2882eb@equibles.com
DTSTAMP:20260828T141203Z
DTSTART;VALUE=DATE:20260909
DTEND;VALUE=DATE:20260910
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference: Julie Brown\, Chief Financial Officer\, w
 ill attend and take part in a fireside chat at the Bernstein’s 23rd Annu
 al Pan-European Strategic Decisions Conference in London on Wednesday\, 9 
 September 2026.
DESCRIPTION:Julie Brown\, Chief Financial Officer\, will attend and take pa
 rt in a fireside chat at the Bernstein’s 23rd Annual Pan-European Strate
 gic Decisions Conference in London on Wednesday\, 9 September 2026.\nThe s
 tart time has not been announced.\nWebcast: https://cc.webcasts.com/bern00
 1/090926a_js/?entity=2_HD36QNE
URL:https://equibles.com/stocks/gsk/events/734fb5aa-48f7-4c6e-bd8a-6b287e28
 82eb
END:VEVENT
BEGIN:VEVENT
UID:16ee43e7-400c-42ef-b077-a10c534b782e@equibles.com
DTSTAMP:20260828T141203Z
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260916
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference: Hesham Abdullah\, SVP\, Global Oncology R
 &D\, will participate at the Morgan Stanley’s 24th Annual Global Healthc
 are Conference in New York on Tuesday\, 15 September 2026.
DESCRIPTION:Hesham Abdullah\, SVP\, Global Oncology R&D\, will participate 
 at the Morgan Stanley’s 24th Annual Global Healthcare Conference in New 
 York on Tuesday\, 15 September 2026.\nThe start time has not been announce
 d.\nWebcast: https://www.globalmeet.com/
END:VEVENT
BEGIN:VEVENT
UID:6dd2ef96-bfa1-4d10-85e3-060a2f15e17f@equibles.com
DTSTAMP:20260917T231844Z
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260924
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference: Julie Brown\, Chief Financial Officer\, w
 ill attend and take part in a fireside chat at the BofA Global Healthcare 
 Conference in London on Wednesday\, 23 September 2026.
DESCRIPTION:Julie Brown\, Chief Financial Officer\, will attend and take pa
 rt in a fireside chat at the BofA Global Healthcare Conference in London o
 n Wednesday\, 23 September 2026.\nThe start time has not been announced.\n
 Webcast: https://kvgo.com/bofa/gsk-sep-2026
URL:https://equibles.com/stocks/gsk/events/6dd2ef96-bfa1-4d10-85e3-060a2f15
 e17f
END:VEVENT
BEGIN:VEVENT
UID:f40d916e-67f2-465c-ad9e-79dc6c667d1f@equibles.com
DTSTAMP:20261003T042706Z
DTSTART;VALUE=DATE:20261028
DTEND;VALUE=DATE:20261029
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Earnings Call\, FY2026 Q3
DESCRIPTION:The start time has not been announced.\nWebcast: https://events
 .zoom.us/ev/At0lka17t_nPyyFfCzy1qJxUIC_JEdu9ZF6cr8cZZWZSoO6i8Nxg~AgEYEuwaj
 d3LNQ4RgsigoijG9U4FblFDNbS3zXfZcbG4aDA7_M7lfj7kSA
URL:https://equibles.com/stocks/gsk/calls/2026-q3
END:VEVENT
BEGIN:VEVENT
UID:491c808d-a337-441e-8e8a-e678963b8468@equibles.com
DTSTAMP:20261009T081451Z
DTSTART;VALUE=DATE:20261110
DTEND;VALUE=DATE:20261111
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference
DESCRIPTION:CONFERENCE\nThe start time has not been announced.\nWebcast: ht
 tps://event.summitcast.com/view/oVDtKqmPn2tPc7VV7WsLAC/guest_book?session_
 id=gAhevJ7NGQHR7WZusBRCgb
URL:https://equibles.com/stocks/gsk/events/491c808d-a337-441e-8e8a-e678963b
 8468
END:VEVENT
BEGIN:VEVENT
UID:4002addd-b73b-44b5-9f4f-c326006044e4@equibles.com
DTSTAMP:20261103T225219Z
DTSTART:20261117T154500Z
DTEND:20261117T164500Z
SEQUENCE:26520739
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Conference
DESCRIPTION:CONFERENCE\nWebcast: https://event.summitcast.com/view/avibSrFu
 fLKeoLRAEgMxy6/hWa8DqLTEWnbwZc6uJk7Pk
URL:https://equibles.com/stocks/gsk/events/4002addd-b73b-44b5-9f4f-c3260060
 44e4
END:VEVENT
BEGIN:VEVENT
UID:200ed038-3563-4a83-acd2-8cae332a4f48@equibles.com
DTSTAMP:20261003T042706Z
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270204
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:GSK plc (GSK) Earnings Call\, FY2026 Q4
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/gsk/calls/2026-q4
END:VEVENT
END:VCALENDAR
